(Q44345402)

2 December 2017

title

Novel thrombin inhibitors incorporating non-basic partially saturated heterobicyclic P1-arginine mimetics (English)

1 reference

2 December 2017

author

Lucija Peterlin-Masic

object named as

Lucija Peterlin-Masic

1

1 reference

ORCID Public Data File 2021

author name string

Gregor Mlinsek

2

1 reference

2 December 2017

Tomaz Solmajer

3

1 reference

2 December 2017

Alenka Trampus-Bakija

4

1 reference

2 December 2017

Mojca Stegnar

5

1 reference

2 December 2017

Danijel Kikelj

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

2 December 2017

published in

1 reference

2 December 2017

volume

13

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

789-794

1 reference

Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

Structure-based design of novel potent nonpeptide thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

Bicyclic pyridones as potent, efficacious and orally bioavailable thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

Non-covalent thrombin inhibitors featuring P(3)-heterocycles with P(1)-monocyclic arginine surrogates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

Novel acylguanidine containing thrombin inhibitors with reduced basicity at the P1 moiety

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

The design of potent, selective, non-covalent, peptide thrombin inhibitors utilizing imidazole as a S1 binding element

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

1-Aminoisoquinoline as benzamidine isoster in the design and synthesis of orally active thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

Novel, potent non-covalent thrombin inhibitors incorporating p(3)-lactam scaffolds

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 position

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

Design and synthesis of potent and highly selective thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

Calculation of inhibitor Ki and inhibitor type from the concentration of inhibitor for 50% inhibition for Michaelis-Menten enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

New thrombin inhibitors based on D-cha-Pro-derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

Non-covalent thrombin inhibitors featuring P3-heterocycles with P1-bicyclic arginine surrogates.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900030-1

7 January 2021

10.1016/S0960-894X(03)00030-1

Identifiers

DOI

1 reference

2 December 2017

1 reference